Twist bioscience corp (TWST)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18
Assets
Current assets
Cash and cash equivalents

184,395

26,032

46,735

68,212

28,693

66,459

80,757

Short-term investments

45,669

77,075

91,372

93,575

75,631

63,707

-

Accounts receivable, net

14,831

13,054

12,104

11,697

7,998

6,978

5,419

Inventories

10,764

7,416

7,330

5,496

4,449

5,561

6,028

Prepaid expenses and other current assets

4,546

5,711

2,594

3,642

4,220

3,958

3,467

Total current assets

260,205

129,288

160,135

182,622

120,991

146,663

95,671

Property and equipment, net

23,266

21,339

20,835

19,817

14,940

13,596

12,331

Operating lease right-of-use assets

35,853

37,238

-

-

-

-

-

Goodwill

1,138

1,138

1,138

1,138

1,138

1,138

1,138

Intangible assets, net

407

458

508

559

610

661

712

Restricted cash, non-current

579

579

579

579

579

579

579

Other non-current assets

2,424

2,237

3,799

2,090

1,912

1,816

5,360

Total assets

323,872

192,277

186,994

206,805

140,170

164,453

115,791

Liabilities and stockholders' equity
Redeemable convertible preferred stock

-

-

-

-

-

-

290,483

Current liabilities
Accounts payable

6,932

9,106

9,760

7,835

4,505

6,725

7,531

Accrued expenses

3,491

4,687

5,965

3,713

2,412

2,606

2,166

Accrued compensation

8,625

8,848

10,479

9,886

7,436

5,261

5,401

Accrued litigation settlement

-

22,500

-

-

-

-

-

Current portion of operating lease liabilities

7,777

8,371

-

-

-

-

-

Current portion of long-term debt

3,333

3,333

3,333

3,333

3,333

3,333

2,500

Other current liabilities

52

999

817

680

894

1,073

939

Total current liabilities

30,210

57,844

30,354

25,447

18,580

18,998

18,537

Operating lease liabilities, net of current portion

26,440

27,539

-

-

-

-

-

Redeemable convertible preferred stock warrant liability

-

-

-

-

-

-

631

Long-term debt, net of current portion

2,925

3,669

4,400

5,119

5,828

6,526

7,218

Other non-current liabilities

95

144

158

236

282

333

344

Total liabilities

59,670

89,196

34,912

30,802

24,690

25,857

26,730

Stockholders' equity
Common stock, $0.00001 par value—100,000,000 shares authorized; 40,970,157 and 32,872,675 shares issued and outstanding as of March 31, 2020 and September 30, 2019, respectively

-

-

-

-

0

0

-

Additional paid-in capital

669,919

477,053

470,425

463,229

375,043

372,066

9,346

Accumulated other comprehensive income

213

190

181

117

-136

24

87

Accumulated deficit

-405,930

-374,162

-318,524

-287,343

-259,427

-233,494

-210,855

Total stockholders' equity

264,202

103,081

152,082

176,003

115,480

138,596

-201,422

Total liabilities and stockholders' equity

323,872

192,277

186,994

206,805

140,170

164,453

115,791

Series A Mezzanine Equity [Member]
Redeemable convertible preferred stock

-

-

-

-

-

-

9,141

Series B Mezzanine Equity [Member]
Redeemable convertible preferred stock

-

-

-

-

-

-

25,900

Series C Mezzanine Equity [Member]
Redeemable convertible preferred stock

-

-

-

-

-

-

36,726

Series D Mezzanine Equity [Member]
Redeemable convertible preferred stock

-

-

-

-

-

-

218,716